Connection

Richard Kovacs to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Richard Kovacs has written about Angiotensin-Converting Enzyme Inhibitors.
Richard Kovacs
Connection Strength
0.175
Angiotensin-Converting Enzyme Inhibitors
  1. The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents. J Am Med Dir Assoc. 2020 Jul; 21(7):909-914.e2.
    View in: PubMed
    Score: 0.117
  2. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. J Card Fail. 2020 05; 26(5):370.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.